Atlas Trials

Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation

Clinical trial NCT06319391 · UNKNOWN

Trial details

NCT number
NCT06319391
Sponsor
Ziqiang Li
Status
UNKNOWN
Study type
OBSERVATIONAL
Complete and Accurate Statistical Data of 60 PatientsCYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed AccuratelyPostoperative Tacrolimus Concentrations Were Accurately Recorded in 60 PatientsAccording to the Diagnosis and Grading Criteria of Acute Kidney Injury, the Cases and Grading of Postoperative Acute Kidney Injury in 60 Patients Were CountedScientific and Rigorous Statistical Analysis of Data
Start date
2023-04-01
Primary completion
2024-05-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.